Lack of association between the -2518G/A polymorphism of the MCP-1 gene and ischaemic heart disease: A family-based investigation

Tissue Antigens

Volumn 64, Issue 2, 2004, Pages 199-203

  McGlinchey, P G ^a   Spence, M S ^a   Patterson, C C ^b   Allen, A R ^c   Murphy, G ^a   Belton, C ^c   McKeown, P P ^a,c  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Gene polymorphism; Ischaemic heart disease; MCP 1

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY; FEMALE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR;

CHEMOKINE CCL2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRELAND; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 3242797289     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-2815.2004.00281.x     Document Type: Article

References (22)

1. Nora JJ, Lortscher RH, Spangler RD, Nora AH, Kimberling WJ. Genetic epidemiologic study of early onset ischemic heart disease. Circulation 1980: 61: 503-8.
2. Shea S, Ottman R, Gabrielli C, Stein Z, Nichols A. Family history as an independent risk factor for coronary artery disease. J Am Coll Cardiol 1984: 4: 793-801.
3. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary artery disease in a study of twins. N Engl J Med 1994: 330: 1041-6.
4. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002: 4: 45-61.
5. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999: 340: 115-26.
6. Adams DH, Lloyd AR. Chemokines: leucocyte recruitment and activation cytokines. Lancet 1997: 349: 490-5.
7. Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999: 259: 344-8.
8. Spielman RS, Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am J Hum Genet 1998: 62: 450-8.
9. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000: 67: 146-54.
10. Spence MS, McGlinchey PG, Patterson CC et al. Family-based investigation of the C677T polymorphism of the methylenetetrahydrofolate reductase gene in ischaemic heart disease. Atherosclerosis 2002: 165: 293-9.
11. Bernard R, Corday E, Eliasch H et al. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organisation task force on standardization of clinical nomenclature. Circulation 1979: 59: 607-9.
12. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. Monograph Series 56, 2nd edn. Geneva: World Health Organization, 1982.
13. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S. The electrocardiogram in population studies. A classification system. Circulation 1960: 21: 1160-75.
14. Miller SA, Dykes DD, Polesky HF. A simple salting procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
15. Szalai C, Duba J, Prohaszka Z et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 2001: 158: 233-9.
16. Curtis D. Use of siblings as controls in case-control association studies. Ann Hum Genet 1997: 61: 319-33.
17. Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, Baggiolini M. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes. Eur J Immunol 1995: 25: 64-8.
18. Taub DD, Proost P, Murphy, WJ et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995: 95: 1370-6.
19. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991: 88: 1121-7.
20. Gu L, Okada Y, Clinton SK et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998: 2: 275-81.
21. Aiello RJ, Bourassa PAK, Lindsey S et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1999: 19: 1518-25.
22. Yamada Y, Izawa H, Ichihara S et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002: 347: 1916-23.